Description of the Product
The Infant Phototherapy Unit YR06218 is a state-of-the-art device designed to provide high-quality phototherapy treatment for newborns suffering from jaundice. This condition is quite prevalent in neonates and requires prompt attention to prevent serious health complications. Equipped with a bilirubin radiancy of 3750 µw/cm² (40cm) and 3200 µw/cm² (50cm), this device ensures effective treatment by delivering optimal light intensity tailored to the baby’s needs.
The unit offers adjustable lighting intensity at 33%, 67%, and 100%, ensuring precise control during therapy sessions. With an emissions spectrum ranging from 400 nm to 550 nm, it covers the essential wavelengths for breaking down bilirubin in the infant’s body. The YR06218 also comes with the functionality of white light, providing flexibility in treatment options and comforting illumination.
The device is powered efficiently, consuming ≤ 60VA, making it both effective and energy-efficient. It features a radiant space of 400 × 250 mm and maintains a radiant uniformity greater than 0.4, which guarantees consistent light distribution across the treatment area. Additionally, users can program therapy durations from 0 to 99 hours and 59 minutes, accommodating the specific needs of each patient.
| Model | YR06218 |
| Bilirubin radiancy (40cm) | 3750 μ w/cm² (62.5 μ w/cm²/nm) |
| Bilirubin radiancy (50cm) | 3200 μ w/cm² (53 μ w/cm²/nm) |
| Lighting intensity | 33%, 67%, 100% |
| White light | Yes |
| Power | ≤ 60VA |
| Wave length | 400nm ~ 550nm |
| Radiant space | 400 × 250mm |
| Radiant Uniformity | > 0.4 |
| Therapy time set | 0-99h59m |
| Life time | 5000 h |
Market Price
In the current market, the Infant Phototherapy Unit YR06218 is priced between 1400 USD to 2200 USD. This range reflects the advanced technology and quality construction of the device, making it a competitive choice for healthcare facilities seeking effective neonatal care solutions.
While the investment in such a crucial device is significant, the benefits it provides in terms of effective treatment and patient outcomes are invaluable. For healthcare providers looking to enhance their neonatal care services, the YR06218 provides a balance of cost-effectiveness and quality.
Frequently Asked Questions
How does phototherapy help in treating neonatal jaundice?
Phototherapy reduces bilirubin levels in the newborn’s blood by breaking down excess bilirubin through light exposure, making it easier for the baby’s body to process and eliminate.
What is the lifespan of the Infant Phototherapy Unit YR06218?
The YR06218 has a lifespan of 5000 hours of continuous use, ensuring durability and reliability for long-term use in clinical settings.
Advantages and Disadvantages
Advantages: The Infant Phototherapy Unit YR06218 offers high efficacy in treating jaundice due to its precisely adjustable light intensity and wavelength coverage. It is energy efficient, with a power consumption of ≤ 60VA, and provides long-term usage with a lifespan of 5000 hours. Furthermore, it offers white light functionality, improving usability and patient comfort.
Disadvantages: One potential drawback could be the initial investment cost, which might be high for smaller healthcare facilities. However, the advanced capabilities and reduced maintenance costs over time can offset this initial expense.
Field Use of the Product
The YR06218 unit is utilized primarily in neonatal wards and pediatric clinics. During treatment, the unit is positioned over the infant, maintaining the recommended distance for effective bilirubin breakdown while minimizing any discomfort. The adjustable intensity settings allow medical personnel to fine-tune treatment protocols according to specific patient needs, making it an indispensable tool in neonatal care.
This product is specifically designed for healthcare environments where precision and quality care are paramount. Routine use is enhanced by its intuitive controls and user-friendly interface, ensuring that healthcare providers can focus on delivering optimal care without technical impediments.
Recommendations
For optimal performance and longevity of the Infant Phototherapy Unit YR06218, it is recommended that regular maintenance and cleaning be conducted as per the manufacturer’s guidelines. Training sessions for medical staff should also be implemented to ensure proper usage and handling of the device, thereby preventing any misuse or accidents.
Additionally, making use of the adjustable therapy time setting based on patient-specific requirements can significantly improve treatment outcomes. For facilities aiming to enhance their care capabilities, integrating the YR06218 into their service offerings is a prudent decision.
If you’re looking for a fusion of innovation and quality, you have arrived at the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each piece with a level of excellence. Our intuitive and agile online shopping channels are designed with your convenience in mind, ensuring the friendliest prices. Don’t hesitate any further, we bring science to life, it’s time to become part of our community. https://kalstein.net/en/product/infant-phototherapy-unit-yr06218/.
